Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Gastrointestinal 1

Conditions

Solid Tumors 2Advanced Colorectal Cancer 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × plocabulin × Clear all
NCT02533674 2021-06-11

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

PharmaMar

Phase 1 Completed
57 enrolled 19 charts
Other solid neoplasm

Solid Tumors

NCT03427268 2021-05-24

Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

PharmaMar

Phase 2 Completed
32 enrolled 22 charts
Gastrointestinal

Advanced Colorectal Cancer

NCT01299636 2015-11-02

Study of PM060184 in Patients With Advanced Solid Tumors

PharmaMar

Phase 1 Completed
60 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡